saintopin has been researched along with dactinomycin in 1 studies
Studies (saintopin) | Trials (saintopin) | Recent Studies (post-2010) (saintopin) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
7 | 0 | 0 | 19,045 | 355 | 969 |
Protein | Taxonomy | saintopin (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanematsu, T; Kawanami, K; Kohno, K; Kuwano, M; Taniguchi, K; Wada, M | 1 |
1 other study(ies) available for saintopin and dactinomycin
Article | Year |
---|---|
Drug-induced down-regulation of topoisomerase I in human epidermoid cancer cells resistant to saintopin and camptothecins.
Topics: Antibiotics, Antineoplastic; Benz(a)Anthracenes; Camptothecin; Carcinoma, Squamous Cell; Dactinomycin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Enzyme Induction; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; KB Cells; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1996 |